FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318484585> ?p ?o ?g. }

• W4318484585 endingPage "e006024" @default.
• W4318484585 startingPage "e006024" @default.
• W4318484585 abstract "Oncolytic virus immunotherapy has revolutionized cancer immunotherapy by efficiently inducing both oncolysis and systemic immune activation. Locoregional administration has been used for oncolytic virus therapy, but its applications to deep-seated cancers have been limited. Although systemic delivery of the oncolytic virus would maximize viral immunotherapy's potential, this remains a hurdle due to the rapid removal of the administered virus by the complement and innate immune system. Infected cells produce some vaccinia viruses as extracellular enveloped virions, which evade complement attack and achieve longer survival by expressing host complement regulatory proteins (CRPs) on the host-derived envelope. Here, we generated SJ-600 series oncolytic vaccinia viruses that can mimic complement-resistant extracellular enveloped virions by incorporating human CRP CD55 on the intracellular mature virion (IMV) membrane.The N-terminus of the human CD55 protein was fused to the transmembrane domains of the six type I membrane proteins of the IMV; the resulting recombinant viruses were named SJ-600 series viruses. The SJ-600 series viruses also expressed human granulocyte-macrophage colony-stimulating factor (GM-CSF) to activate dendritic cells. The viral thymidine kinase (J2R) gene was replaced by genes encoding the CD55 fusion proteins and GM-CSF.SJ-600 series viruses expressing human CD55 on the IMV membrane showed resistance to serum virus neutralization. SJ-607 virus, which showed the highest CD55 expression and the highest resistance to serum complement-mediated lysis, exhibited superior anticancer activity in three human cancer xenograft models, compared with the control Pexa-Vec (JX-594) virus, after single-dose intravenous administration. The SJ-607 virus administration elicited neutralizing antibody formation in two immunocompetent mouse strains like the control JX-594 virus. Remarkably, we found that the SJ-607 virus evades neutralization by vaccinia virus-specific antibodies.Our new oncolytic vaccinia virus platform, which expresses human CD55 protein on its membrane, prolonged viral survival by protecting against complement-mediated lysis and by evading neutralization by vaccinia virus-specific antibodies; this may provide a continuous antitumor efficacy until a complete remission has been achieved. Such a platform may expand the target cancer profile to include deep-seated cancers and widespread metastatic cancers." @default.
• W4318484585 created "2023-01-30" @default.
• W4318484585 creator A5006316348 @default.
• W4318484585 creator A5013634972 @default.
• W4318484585 creator A5016707478 @default.
• W4318484585 creator A5018702499 @default.
• W4318484585 creator A5023817508 @default.
• W4318484585 creator A5046218009 @default.
• W4318484585 creator A5047785022 @default.
• W4318484585 creator A5049270876 @default.
• W4318484585 creator A5050253400 @default.
• W4318484585 creator A5068871744 @default.
• W4318484585 date "2023-01-01" @default.
• W4318484585 modified "2023-10-01" @default.
• W4318484585 title "Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies" @default.
• W4318484585 cites W1913328895 @default.
• W4318484585 cites W1965497380 @default.
• W4318484585 cites W1980219722 @default.
• W4318484585 cites W1988337918 @default.
• W4318484585 cites W1989186015 @default.
• W4318484585 cites W1997481878 @default.
• W4318484585 cites W1998836839 @default.
• W4318484585 cites W2010094323 @default.
• W4318484585 cites W2012611138 @default.
• W4318484585 cites W2017440688 @default.
• W4318484585 cites W2026272606 @default.
• W4318484585 cites W2038853909 @default.
• W4318484585 cites W2042741115 @default.
• W4318484585 cites W2043889392 @default.
• W4318484585 cites W2064442490 @default.
• W4318484585 cites W2076674654 @default.
• W4318484585 cites W2093059993 @default.
• W4318484585 cites W2097047387 @default.
• W4318484585 cites W2097225513 @default.
• W4318484585 cites W2100170686 @default.
• W4318484585 cites W2101058247 @default.
• W4318484585 cites W2109274792 @default.
• W4318484585 cites W2116184472 @default.
• W4318484585 cites W2118524399 @default.
• W4318484585 cites W2128033630 @default.
• W4318484585 cites W2137906256 @default.
• W4318484585 cites W2150941981 @default.
• W4318484585 cites W2155402817 @default.
• W4318484585 cites W2260107522 @default.
• W4318484585 cites W2316811173 @default.
• W4318484585 cites W2344200954 @default.
• W4318484585 cites W2466689966 @default.
• W4318484585 cites W2750781282 @default.
• W4318484585 cites W2795842962 @default.
• W4318484585 cites W2796593579 @default.
• W4318484585 cites W2801821552 @default.
• W4318484585 cites W2805716754 @default.
• W4318484585 cites W2904883738 @default.
• W4318484585 cites W2938889495 @default.
• W4318484585 cites W2999918121 @default.
• W4318484585 cites W3006950074 @default.
• W4318484585 cites W3008217150 @default.
• W4318484585 cites W3017024453 @default.
• W4318484585 cites W3092306917 @default.
• W4318484585 cites W3121622320 @default.
• W4318484585 cites W3126201322 @default.
• W4318484585 cites W3160126603 @default.
• W4318484585 cites W3198188086 @default.
• W4318484585 cites W4206739027 @default.
• W4318484585 cites W4211238487 @default.
• W4318484585 cites W4213324290 @default.
• W4318484585 cites W4214544393 @default.
• W4318484585 cites W4220838533 @default.
• W4318484585 cites W4225718747 @default.
• W4318484585 cites W4229012308 @default.
• W4318484585 doi "https://doi.org/10.1136/jitc-2022-006024" @default.
• W4318484585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36717184" @default.
• W4318484585 hasPublicationYear "2023" @default.
• W4318484585 type Work @default.
• W4318484585 citedByCount "0" @default.
• W4318484585 crossrefType "journal-article" @default.
• W4318484585 hasAuthorship W4318484585A5006316348 @default.
• W4318484585 hasAuthorship W4318484585A5013634972 @default.
• W4318484585 hasAuthorship W4318484585A5016707478 @default.
• W4318484585 hasAuthorship W4318484585A5018702499 @default.
• W4318484585 hasAuthorship W4318484585A5023817508 @default.
• W4318484585 hasAuthorship W4318484585A5046218009 @default.
• W4318484585 hasAuthorship W4318484585A5047785022 @default.
• W4318484585 hasAuthorship W4318484585A5049270876 @default.
• W4318484585 hasAuthorship W4318484585A5050253400 @default.
• W4318484585 hasAuthorship W4318484585A5068871744 @default.
• W4318484585 hasBestOaLocation W43184845851 @default.
• W4318484585 hasConcept C104317684 @default.
• W4318484585 hasConcept C111684460 @default.
• W4318484585 hasConcept C136449434 @default.
• W4318484585 hasConcept C138873322 @default.
• W4318484585 hasConcept C14356644 @default.
• W4318484585 hasConcept C159047783 @default.
• W4318484585 hasConcept C203014093 @default.
• W4318484585 hasConcept C2522874641 @default.
• W4318484585 hasConcept C2779094796 @default.
• W4318484585 hasConcept C2779827044 @default.
• W4318484585 hasConcept C2781356689 @default.

• next